Nerve Block Versus Non-targeted Local Anaesthesia in Breast Surgery
A Prospective, Randomised Double Blinded Study Comparing a Pectoral Nerve Block With Non-targeted Local Anaesthetic in Bilateral Breast Surgery
1 other identifier
interventional
50
1 country
1
Brief Summary
Effective postoperative pain control is an essential component of surgery. Adequate analgesia improves patient comfort and satisfaction, thereby permitting earlier mobilisation, faster recovery and less likelihood of complications.The majority of surgeons will place 10ml of local anaesthetic into the breast pocket or inject it into the breast skin following breast surgery. A more specific technique is to identify the nerves supplying the breast and put the local anaesthetic directly around them (Pec block). This nerve block has recently been described and is increasingly being used by anaesthetists for surgery under local anaesthetic or for post-operative analgesia. It has been shown to provide better and more specific pain relief in several studies. Anaesthetists use an ultrasound machine to identify the anatomical landmarks for the nerves and they inject into the vicinity. They do not have direct vision and there is a risk of causing morbidity or the block not being effective. It is much easier for a surgeon to apply the block, as they can see the anatomical landmarks. Despite this, very few surgeons are aware of the technique. The study group consists of patients undergoing bilateral cosmetic breast surgery at BMI Edgbaston and Priory hospitals and Spire Parkway and Southbank hospitals in Birmingham and Worcester. If a patient consents to being involved in the research, they will have one breast randomised to receiving a pec block and the contralateral (opposite) breast will receive the same amount of local anaesthetic placed in the breast pocket in a non-targeted fashion. The patients and researcher will be blinded as to the allocation. Patients will complete a verbal numeric pain score for each breast at set intervals until they are discharged.In addition, the investigators will specifically ask which breast is the most painful at each time point. The results of the study may improve patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2015
CompletedFirst Posted
Study publicly available on registry
April 8, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedJuly 26, 2016
July 1, 2016
8 months
March 31, 2015
July 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
targeted question as to which breast is more painful
patient is asked which breast is more painful
3 hours post-operatively
Secondary Outcomes (1)
verbal numeric rating scale(VNRS)
3 hours post-operatively
Study Arms (2)
standard chirocaine infiltration
ACTIVE COMPARATORnon-targeted infiltration of 10ml 0.25% Chirocaine into breast pocket
targeted chirocaine pec block
EXPERIMENTALpectoral muscle block with 10ml 0.25% chirocaine
Interventions
10ml 0.25% chirocaine in a specifically targeted in a nerve block
10ml 0.25% chirocaine is infiltrated into breast pocket in a non targeted fashion
A dose of morphine 0.1mg/kg will be given intra-operatively. Thereafter morphine 0.1mg/kg will be given for breakthrough pain. Patients will be prescribed regular paracetamol and ibuprofen.
Eligibility Criteria
You may qualify if:
- Patient requesting a bilateral breast procedure (reduction, mastopexy or augmentation).
- Patient willing to sign the informed consent form agreeing to its items after explanation of the study by the operating surgeon.
You may not qualify if:
- Declining to give written consent.
- History of allergy to chirocaine local anaesthetic.
- Prior breast surgery.
- Chronic pain disorder.
- Significant medical co-morbidities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BMI Healthcarelead
Study Sites (1)
Edgbaston BMI Hospital
Birmingham, West Midlands, B152QQ, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
anne dancey, MBChB(hons)
AAS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Plastic Surgeon
Study Record Dates
First Submitted
March 31, 2015
First Posted
April 8, 2015
Study Start
January 1, 2016
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
July 26, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will share
yes on individual request of the patient when study is completed